Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0%Debt Paydown Yield
VS
Market
Sector
Industry
History
$ 9.08Close
$ 2.9 - $ 9.34 52-Week Range
Ticker Information
Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXERIS BIOPHARMA HOLDINGS INC - Debt Paydown Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XERS - Debt Paydown Yield Historical data
| Date | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
|---|---|---|---|
| 6/30/2025 | 0% | $ 1.07B | $ 0 |
| 3/31/2025 | 0% | $ 826.4M | $ 0 |
| 12/31/2024 | -6% | $ 635.77M | $ 38.17M |
| 9/30/2024 | -7.15% | $ 517.31M | $ 36.98M |
| 6/30/2024 | -11.13% | $ 332.27M | $ 36.98M |
| 3/31/2024 | -13.27% | $ 278.72M | $ 36.98M |
| 12/31/2023 | 0.34% | $ 348.32M | $ -1.19M |
| 9/30/2023 | -19.6% | $ 249.31M | $ 48.86M |
| 6/30/2023 | -13.67% | $ 356.21M | $ 48.7M |
| 3/31/2023 | -12.94% | $ 374.86M | $ 48.5M |
Key Performance Insights, Last 5 Years
- XERIS BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) Debt Paydown Yield stands at -21.58%.
- Over the past 5 years, XERIS BIOPHARMA HOLDINGS INC's average Debt Paydown Yield has been -14.21%.
- The median Debt Paydown Yield for XERIS BIOPHARMA HOLDINGS INC during this period was -13.1%
- XERIS BIOPHARMA HOLDINGS INC reached its highest Debt Paydown Yield over the past 5 years at 0.34%.
- The lowest Debt Paydown Yield recorded by XERIS BIOPHARMA HOLDINGS INC in the same timeframe -52.39%
XERIS BIOPHARMA HOLDINGS INC's Debt Paydown Yield vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt Paydown Yield Benchmarks
Similar metrics to CF - Debt:
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
Definition of Debt Paydown Yield
[Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield Debt Paydown Yield for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: (-1 * CF - Debt [ $ 60.66M ]) / Market Cap [ $ 281.12M ]
(=) Debt Paydown Yield [ -21.58% ] XERS - Debt Paydown Yield, Last 5 years
-52.39%
Minimum
Dec 31, 2022
0.34%
Maximum
Dec 31, 2023
-14.21%
Average
-13.1%
Median
Debt Paydown Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Debt Paydown Yield for companies in the Total Stock Market. The average Debt Paydown Yield of the companies is -0.08% with a standard deviation of 3.82%.
The following table provides additional summary stats:
Debt Paydown Yield in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -11.5% |
| max | 11.49% |
| average | -0.08% |
| median | 0% |
| std | 3.82% |